United States
-
Ultragenyx to Present at Evercore 4th Annual HealthconX Conference
NOVATO, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that…
Read More »